Pharmacogenomic Profiling in Personalized Therapeutics: Predicting Drug Response in High-Risk Patients with Cardiometabolic Disorders. Med. Int. J. Health Med. Res. 2025;1(01):28-37. Accessed October 24, 2026. https://research-education.com/index.php/ijhmr/article/view/6